Evidence map›Paper›PMID 36080498›Full record

ArticleMolecules (Basel, Switzerland)2022

New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture.

Alexey Sulimov, Ivan Ilin, Danil Kutov, Khidmet Shikhaliev, Dmitriy Shcherbakov, Oleg Pyankov, Nadezhda Stolpovskaya, Svetlana Medvedeva, Vladimir Sulimov

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alexey SulimovDimonta Ltd., 15 Nagornaya Str., Bldg 8, 117186 Moscow, Russia.
Ivan IlinDimonta Ltd., 15 Nagornaya Str., Bldg 8, 117186 Moscow, Russia.
Danil KutovDimonta Ltd., 15 Nagornaya Str., Bldg 8, 117186 Moscow, Russia.ORCID 0000-0002-4777-6522
Khidmet ShikhalievDepartment of Organic Chemistry, Faculty of Chemistry, Voronezh State University, 1 Universitetskaya Sq., 394018 Voronezh, Russia.
Dmitriy ShcherbakovState Research Centre of Virology and Biotechnology "Vector", 630559 Koltsovo, Russia.ORCID 0000-0001-8023-4453
Oleg PyankovState Research Centre of Virology and Biotechnology "Vector", 630559 Koltsovo, Russia.
Nadezhda StolpovskayaDepartment of Organic Chemistry, Faculty of Chemistry, Voronezh State University, 1 Universitetskaya Sq., 394018 Voronezh, Russia.ORCID 0000-0002-1819-6414
Svetlana MedvedevaDepartment of Organic Chemistry, Faculty of Chemistry, Voronezh State University, 1 Universitetskaya Sq., 394018 Voronezh, Russia.ORCID 0000-0003-0073-1084
Vladimir SulimovDimonta Ltd., 15 Nagornaya Str., Bldg 8, 117186 Moscow, Russia.
Lomonosov Moscow State University · RUVoronezh State University · RUState Research Center of Virology and Biotechnology VECTOR · RU

Funding

Russian Science Foundation 21-71-20031
6 · The paper itself

Abstract

Candidates to being inhibitors of the main protease (Mpro) of SARS-CoV-2 were selected from the database of Voronezh State University using molecular modeling. The database contained approximately 19,000 compounds represented by more than 41,000 ligand conformers. These ligands were docked into Mpro using the SOL docking program. For one thousand ligands with best values of the SOL score, the protein-ligand binding enthalpy was calculated by the PM7 quantum-chemical method with the COSMO solvent model. Using the SOL score and the calculated protein-ligand binding enthalpies, eighteen compounds were selected for the experiments. Several of these inhibitors suppressed the replication of the coronavirus in cell culture, and we used the best three among them in the search for chemical analogs. Selection among analogs using the same procedure followed by experiments led to identification of seven inhibitors of the SARS-CoV-2 replication in cell culture with EC50 values at the micromolar level. The identified inhibitors belong to three chemical classes. The three inhibitors, 4,4-dimethyldithioquinoline derivatives, inhibit SARS-CoV-2 replication in Vero E6 cell culture just as effectively as the best published non-covalent inhibitors, and show low cytotoxicity. These results open up a possibility to develop antiviral drugs against the SARS-CoV-2 coronavirus.

Indexed as

COVID-19 Drug TreatmentSARS-CoV-2Antiviral AgentsCell Culture TechniquesCoronavirus 3C ProteasesCysteine EndopeptidasesHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationProtease InhibitorsViral Nonstructural ProteinsAntiviral AgentsCoronavirus 3C ProteasesCysteine EndopeptidasesLigandsProtease InhibitorsViral Nonstructural Proteinscell culturedockinginhibitorsmain proteasequantum chemistrySARS-CoV-2 replication

Identifiers

PMID36080498
PMCPMC9457583
OpenAlexW4295079739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.